Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Albendazole, Tribendimidine, and Praziquantel for Clonorchiasis in Guangxi
NCT07074444Recruiting
- Sponsor
- The First Affiliated Hospital of Guangxi Medical University
- Start
- Jul 2025
- Primary completion
- Feb 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of albendazole and tribendimidine in clonorchiasis (3 arms), sponsored by The First Affiliated Hospital of Guangxi Medical University. Primary endpoint: Egg Clearance Rate at 4 months. Started Jul 2025; status: recruiting.
02
Drugs
albendazoletribendimidine
03
Conditions
clonorchiasis
Beyond the preview
Go deeper on NCT07074444.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07074444.